Citigroup Inc Jasper Therapeutics, Inc. Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$1.48 - $2.74 $95,918 - $177,579
64,810 New
64,810 $117,000
Q2 2022

Aug 10, 2022
BUY
$1.73 - $3.86 $337 - $752
195 New
195 $0

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0
View Full List

About Jasper Therapeutics, Inc.

JSPR Quotes by TradingView
  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $821M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email